vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Magnera Corp (MAGN). Click either name above to swap in a different company.
Magnera Corp is the larger business by last-quarter revenue ($792.0M vs $487.7M, roughly 1.6× CLOVER HEALTH INVESTMENTS, CORP.). Magnera Corp runs the higher net margin — -4.3% vs -10.1%, a 5.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 12.8%). Magnera Corp produced more free cash flow last quarter ($-13.0M vs $-69.0M). Over the past eight quarters, Magnera Corp's revenue compounded faster (54.9% CAGR vs 18.6%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
CLOV vs MAGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $792.0M |
| Net Profit | $-49.3M | $-34.0M |
| Gross Margin | — | 12.2% |
| Operating Margin | -10.1% | 1.8% |
| Net Margin | -10.1% | -4.3% |
| Revenue YoY | 44.7% | 12.8% |
| Net Profit YoY | -123.2% | 43.3% |
| EPS (diluted) | — | $-0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | $792.0M | ||
| Q3 25 | $496.6M | — | ||
| Q2 25 | $477.6M | $839.0M | ||
| Q1 25 | $462.3M | $824.0M | ||
| Q4 24 | $337.0M | $702.0M | ||
| Q3 24 | $331.0M | $332.1M | ||
| Q2 24 | $356.3M | $556.0M | ||
| Q1 24 | $346.9M | $558.0M |
| Q4 25 | $-49.3M | $-34.0M | ||
| Q3 25 | $-24.4M | — | ||
| Q2 25 | $-10.6M | $-18.0M | ||
| Q1 25 | $-1.3M | $-41.0M | ||
| Q4 24 | $-22.1M | $-60.0M | ||
| Q3 24 | $-9.2M | $-15.2M | ||
| Q2 24 | $7.4M | $19.0M | ||
| Q1 24 | $-19.2M | $14.0M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 10.7% | ||
| Q1 25 | — | 10.7% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | 24.5% | 10.7% | ||
| Q2 24 | 30.3% | 6.6% | ||
| Q1 24 | 23.6% | 6.2% |
| Q4 25 | -10.1% | 1.8% | ||
| Q3 25 | -4.9% | — | ||
| Q2 25 | -2.2% | 1.5% | ||
| Q1 25 | -0.3% | 0.5% | ||
| Q4 24 | -6.4% | -3.1% | ||
| Q3 24 | -2.7% | 0.9% | ||
| Q2 24 | 2.0% | 3.1% | ||
| Q1 24 | -6.5% | 3.8% |
| Q4 25 | -10.1% | -4.3% | ||
| Q3 25 | -4.9% | — | ||
| Q2 25 | -2.2% | -2.1% | ||
| Q1 25 | -0.3% | -5.0% | ||
| Q4 24 | -6.6% | -8.5% | ||
| Q3 24 | -2.8% | -4.6% | ||
| Q2 24 | 2.1% | 3.4% | ||
| Q1 24 | -5.5% | 2.5% |
| Q4 25 | — | $-0.95 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-0.51 | ||
| Q1 25 | — | $-1.15 | ||
| Q4 24 | — | $-1.69 | ||
| Q3 24 | — | $-0.33 | ||
| Q2 24 | — | $0.60 | ||
| Q1 24 | — | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $264.0M |
| Total DebtLower is stronger | — | $1.9B |
| Stockholders' EquityBook value | $308.7M | $1.0B |
| Total Assets | $541.0M | $3.9B |
| Debt / EquityLower = less leverage | — | 1.86× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $264.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $276.0M | ||
| Q1 25 | — | $282.0M | ||
| Q4 24 | $194.5M | $215.0M | ||
| Q3 24 | $288.0M | $230.0M | ||
| Q2 24 | $254.8M | $33.9M | ||
| Q1 24 | $208.3M | $30.2M |
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $877.4M | ||
| Q1 24 | — | $884.7M |
| Q4 25 | $308.7M | $1.0B | ||
| Q3 25 | $340.9M | — | ||
| Q2 25 | $344.2M | $1.1B | ||
| Q1 25 | $336.1M | $1.1B | ||
| Q4 24 | $341.1M | $1.1B | ||
| Q3 24 | $342.2M | $2.1B | ||
| Q2 24 | $324.9M | $2.4B | ||
| Q1 24 | $292.5M | $2.4B |
| Q4 25 | $541.0M | $3.9B | ||
| Q3 25 | $559.7M | — | ||
| Q2 25 | $575.0M | $4.1B | ||
| Q1 25 | $583.7M | $4.1B | ||
| Q4 24 | $580.7M | $4.0B | ||
| Q3 24 | $653.0M | $2.8B | ||
| Q2 24 | $674.2M | $1.5B | ||
| Q1 24 | $671.8M | $1.5B |
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.77× | ||
| Q1 25 | — | 1.83× | ||
| Q4 24 | — | 1.80× | ||
| Q3 24 | — | 0.91× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $2.0M |
| Free Cash FlowOCF − Capex | $-69.0M | $-13.0M |
| FCF MarginFCF / Revenue | -14.1% | -1.6% |
| Capex IntensityCapex / Revenue | 0.4% | 1.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | $2.0M | ||
| Q3 25 | $12.1M | — | ||
| Q2 25 | $5.4M | $0 | ||
| Q1 25 | $-16.3M | $65.0M | ||
| Q4 24 | $34.8M | $-58.0M | ||
| Q3 24 | $50.0M | $12.2M | ||
| Q2 24 | $44.8M | $38.0M | ||
| Q1 24 | $25.9M | $20.0M |
| Q4 25 | $-69.0M | $-13.0M | ||
| Q3 25 | $11.4M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $-16.5M | $42.0M | ||
| Q4 24 | $33.3M | $-74.0M | ||
| Q3 24 | $49.6M | $3.6M | ||
| Q2 24 | $44.4M | $23.0M | ||
| Q1 24 | $25.5M | $12.5M |
| Q4 25 | -14.1% | -1.6% | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -3.6% | 5.1% | ||
| Q4 24 | 9.9% | -10.5% | ||
| Q3 24 | 15.0% | 1.1% | ||
| Q2 24 | 12.5% | 4.1% | ||
| Q1 24 | 7.3% | 2.2% |
| Q4 25 | 0.4% | 1.9% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | 1.5% | ||
| Q1 25 | 0.0% | 2.8% | ||
| Q4 24 | 0.5% | 2.3% | ||
| Q3 24 | 0.1% | 2.6% | ||
| Q2 24 | 0.1% | 2.7% | ||
| Q1 24 | 0.1% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | 2.00× | ||
| Q1 24 | — | 1.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
MAGN
| Other | $451.0M | 57% |
| United States And Canada | $341.0M | 43% |
